Orai3 and Orai1 mediate CRAC channel function and metabolic reprogramming in B cells

  1. Scott M Emrich
  2. Ryan E Yoast
  3. Xuexin Zhang
  4. Adam J Fike
  5. Yin-Hu Wang
  6. Kristen N Bricker
  7. Anthony Y Tao
  8. Ping Xin
  9. Vonn Walter
  10. Martin T Johnson
  11. Trayambak Pathak
  12. Adam C Straub
  13. Stefan Feske
  14. Ziaur SM Rahman
  15. Mohamed Trebak  Is a corresponding author
  1. Pennsylvania State University, United States
  2. New York University Langone Medical Center, United States
  3. University of Pittsburgh, United States

Abstract

The essential role of store-operated Ca2+ entry (SOCE) through Ca2+ release-activated Ca2+ (CRAC) channels in T cells is well established. In contrast, the contribution of individual Orai isoforms to SOCE and their downstream signaling functions in B cells are poorly understood. Here, we demonstrate changes in expression of Orai isoforms in response to B cell activation. We show that both Orai3 and Orai1 mediate native CRAC channels in B cells. The combined loss of Orai1 and Orai3, but not Orai3 alone, impairs SOCE, proliferation and survival, nuclear factor of activated T cells (NFAT) activation, mitochondrial respiration, glycolysis, and the metabolic reprogramming of primary B cells in response to antigenic stimulation. Nevertheless, combined deletion of Orai1 and Orai3 in B cells did not compromise humoral immunity to influenza A virus infection in mice, suggesting that other in vivo co-stimulatory signals can overcome the requirement of BCR-mediated CRAC channel function in B cells. Our results shed important new light on the physiological roles of Orai1 and Orai3 proteins in SOCE and effector functions of B lymphocytes.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file

Article and author information

Author details

  1. Scott M Emrich

    Department of Cellular and Molecular Physiology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
  2. Ryan E Yoast

    Department of Cellular and Molecular Physiology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
  3. Xuexin Zhang

    Department of Cellular and Molecular Physiology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
  4. Adam J Fike

    Department of Microbiology and Immunology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
  5. Yin-Hu Wang

    Department of Pathology, New York University Langone Medical Center, New York, United States
    Competing interests
    No competing interests declared.
  6. Kristen N Bricker

    Department of Microbiology and Immunology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8963-9780
  7. Anthony Y Tao

    Department of Pathology, New York University Langone Medical Center, New York, United States
    Competing interests
    No competing interests declared.
  8. Ping Xin

    Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  9. Vonn Walter

    Department of Public Health Sciences, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6114-6714
  10. Martin T Johnson

    Department of Cellular and Molecular Physiology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
  11. Trayambak Pathak

    Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  12. Adam C Straub

    Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    Adam C Straub, owns stock options and is a consultant for Creegh Pharmaceuticals..
  13. Stefan Feske

    4Department of Pathology, New York University Langone Medical Center, New York, United States
    Competing interests
    Stefan Feske, is scientific co-founder of Calcimedica..
  14. Ziaur SM Rahman

    Department of Microbiology and Immunology, Pennsylvania State University, Hershey, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8431-9681
  15. Mohamed Trebak

    Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States
    For correspondence
    TREBAKM@PITT.EDU
    Competing interests
    Mohamed Trebak, Reviewing editor, eLife.Is a consultant for Seeker Biologics Inc..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6759-864X

Funding

National Heart, Lung, and Blood Institute (R35-HL150778)

  • Mohamed Trebak

National Institute of Allergy and Infectious Diseases (R01-AI162971)

  • Ziaur SM Rahman

National Institute of Allergy and Infectious Diseases (R01-AI097302 and R01-AI130143)

  • Stefan Feske

National Institute of Allergy and Infectious Diseases (F30-AI164803-01)

  • Anthony Y Tao

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of Penn State University: Protocols #: 46290, 47477, and 47350

Copyright

© 2023, Emrich et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,655
    views
  • 283
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Scott M Emrich
  2. Ryan E Yoast
  3. Xuexin Zhang
  4. Adam J Fike
  5. Yin-Hu Wang
  6. Kristen N Bricker
  7. Anthony Y Tao
  8. Ping Xin
  9. Vonn Walter
  10. Martin T Johnson
  11. Trayambak Pathak
  12. Adam C Straub
  13. Stefan Feske
  14. Ziaur SM Rahman
  15. Mohamed Trebak
(2023)
Orai3 and Orai1 mediate CRAC channel function and metabolic reprogramming in B cells
eLife 12:e84708.
https://doi.org/10.7554/eLife.84708

Share this article

https://doi.org/10.7554/eLife.84708

Further reading

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Eva Herdering, Tristan Reif-Trauttmansdorff ... Ruth Anne Schmitz
    Research Article

    Glutamine synthetases (GS) are central enzymes essential for the nitrogen metabolism across all domains of life. Consequently, they have been extensively studied for more than half a century. Based on the ATP-dependent ammonium assimilation generating glutamine, GS expression and activity are strictly regulated in all organisms. In the methanogenic archaeon Methanosarcina mazei, it has been shown that the metabolite 2-oxoglutarate (2-OG) directly induces the GS activity. Besides, modulation of the activity by interaction with small proteins (GlnK1 and sP26) has been reported. Here, we show that the strong activation of M. mazei GS (GlnA1) by 2-OG is based on the 2-OG dependent dodecamer assembly of GlnA1 by using mass photometry (MP) and single particle cryo-electron microscopy (cryo-EM) analysis of purified strep-tagged GlnA1. The dodecamer assembly from dimers occurred without any detectable intermediate oligomeric state and was not affected in the presence of GlnK1. The 2.39 Å cryo-EM structure of the dodecameric complex in the presence of 12.5 mM 2-OG demonstrated that 2-OG is binding between two monomers. Thereby, 2-OG appears to induce the dodecameric assembly in a cooperative way. Furthermore, the active site is primed by an allosteric interaction cascade caused by 2-OG-binding towards an adaption of an open active state conformation. In the presence of additional glutamine, strong feedback inhibition of GS activity was observed. Since glutamine dependent disassembly of the dodecamer was excluded by MP, feedback inhibition most likely relies on the binding of glutamine to the catalytic site. Based on our findings, we propose that under nitrogen limitation the induction of M. mazei GS into a catalytically active dodecamer is not affected by GlnK1 and crucially depends on the presence of 2-OG.